1. The Caspase-3/PKCδ/Akt/VEGF-A Signaling Pathway Mediates Tumor Repopulation during Radiotherapy
    Jin Cheng et al, 2019, Clinical Cancer Research CrossRef
  2. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
    Yuxin Zhao et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  3. Küçük hücreli dışı akciğer kanserlerinde endoglin, CD31 ve VEGFR2 ile saptanan mikrodamar yoğunluğu ve sağkalıma etkisi
    Hülya ÇETİN et al, 2021, Pamukkale Medical Journal CrossRef
  4. Unfolded protein response and angiogenesis in malignancies
    Amin Izadpanah et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  5. Enhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non–small-cell Lung Cancer
    Laura Espana-Serrano et al, 2016, Molecular Therapy - Nucleic Acids CrossRef
  6. Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer
    Jigar D. Vanza et al, 2020, Journal of Drug Delivery Science and Technology CrossRef
  7. Antiplasmodial and anticancer activities of xanthones isolated from Garcinia bancana Miq.
    null Rifaldi et al, 2024, Natural Product Research CrossRef
  8. p-21 Activated Kinase as a Molecular Target for Chemoprevention in Diabetes
    Kyle Dammann et al, 2018, Geriatrics CrossRef
  9. Comparison of vascular endothelial growth factor/vascular endothelial growth factor receptor 2 expression and its relationship to tumor cell proliferation in canine epithelial and mesenchymal tumors
    Mayu KIMURA et al, 2022, Journal of Veterinary Medical Science CrossRef
  10. Effect of etoposide plus thalidomide as maintenance therapy on progression-free survival of elderly patients with advanced non-small cell lung cancer
    Yanan Ge et al, 2017, Oncology and Translational Medicine CrossRef
  11. Comparison of cancer cells cultured in 2D vs 3D reveals differences in AKT/mTOR/S6-kinase signaling and drug response
    Angelika Riedl et al, 2016, Journal of Cell Science CrossRef
  12. Advances in Lung Cancer Treatment Using Nanomedicines
    Akshansh Sharma et al, 2023, ACS Omega CrossRef
  13. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo
    Mao-Chi Weng et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  14. Hypoxia and HIF pathway in cancer and the placenta
    Philip S. Macklin et al, 2017, Placenta CrossRef
  15. Biomolecules Involved in Both Metastasis and Placenta Accreta Spectrum—Does the Common Pathophysiological Pathway Exist?
    Anna K. Rekowska et al, 2023, Cancers CrossRef
  16. Vascular endothelial growth factor levels in patients with obstructive sleep apnea: a meta-analysis
    Xiao-Bin Zhang et al, 2017, European Archives of Oto-Rhino-Laryngology CrossRef
  17. Prothrombotic Factors in Obstructive Sleep Apnea: A Systematic Review With Meta-Analysis
    Yue Qiu et al, 2022, Ear, Nose & Throat Journal CrossRef
  18. Emerging role of phytochemicals in targeting predictive, prognostic, and diagnostic biomarkers of lung cancer
    Jyoti Singh et al, 2020, Food and Chemical Toxicology CrossRef
  19. Cediranib Induces Apoptosis, G1 Phase Cell Cycle Arrest, and Autophagy in Non-Small-Cell Lung Cancer Cell A549 In Vitro
    Menghuan Guo et al, 2021, BioMed Research International CrossRef
  20. High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action—A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay
    Dorothea M. Heuberger et al, 2022, Cancers CrossRef
  21. Cancer-derived exosomal miR-197-3p confers angiogenesis via targeting TIMP2/3 in lung adenocarcinoma metastasis
    Rui-Min Chang et al, 2022, Cell Death & Disease CrossRef
  22. Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition
    Velina S. Atanasova et al, 2023, International Journal of Molecular Sciences CrossRef
  23. Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival
    Takashi Higuchi et al, 2020, Translational Oncology CrossRef
  24. VEGF as a potential target in lung cancer
    Daniela Frezzetti et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
  25. Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity
    Nevine M.Y. Elsayed et al, 2019, Bioorganic Chemistry CrossRef